Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.
Despite reporting a rise in sales, the Vodafone share price fell 7%. Our writer looks at the reasons why the turnaround plan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback